BioWorld Asia

April 23, 2003

Celltech Brings On New CEO Following Purchase Of OGS

LONDON - It was all change last week as members of the Oxford GlycoSciences plc board resigned to make way for directors from its new owner, Celltech Group plc, and Celltech announced the appointment of its new CEO, Goran Ando. (BioWorld International) Read More

Gamma Capital Bucks Austrian Trend, Closes New Venture Round

Recombinant BCG Boosts TB Protection In Animal Studies

Affibody, InforSense Release Tool For Data Interpretation

CeNeS Sells Three Products To Strengthen Cash Position

Cellectis Licenses Technology To Nucleis For Gene Insertion

Oxford BioMedica Cuts Back On Programs To Extend Cash

Progress In Two Early Programs Gives Xenova Much-Needed Lift

French Researchers Find Gene Linked To Kindler's Syndrome

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...